CHUGAI PHARMACEUTICAL CO., LTD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,764 JPY | -0.89% |
|
-5.40% | -10.82% |
| May. 23 | Tech stocks lift Japan's Nikkei on boost from Nvidia's robust outlook | RE |
| May. 14 | Japan's Nikkei drifts sideways as more earnings, US CPI awaited | RE |
| Sales 2024 * | 1,089B 6.94B | Sales 2025 * | 1,130B 7.2B | Capitalization | 7,909B 50.39B |
|---|---|---|---|---|---|
| Net income 2024 * | 345B 2.2B | Net income 2025 * | 367B 2.34B | EV / Sales 2024 * | 6.49 x |
| Net cash position 2024 * | 837B 5.33B | Net cash position 2025 * | 1,020B 6.5B | EV / Sales 2025 * | 6.09 x |
| P/E ratio 2024 * |
22.9
x | P/E ratio 2025 * |
21.6
x | Employees | 7,604 |
| Yield 2024 * |
1.76% | Yield 2025 * |
1.85% | Free-Float | 38.08% |
More Fundamentals
* Assessed data
More news
Latest transcript on Chugai Pharmaceutical Co., Ltd
More recommendations
More press releases
| 1 day | -0.89% | ||
| 1 week | -5.40% | ||
| Current month | -5.66% | ||
| 1 month | -1.81% | ||
| 3 months | -20.60% | ||
| 6 months | -4.72% | ||
| Current year | -10.82% |
1 week
4 702.00
5 005.00
1 month
4 687.005 159.00
Current year
4 687.006 697.00
1 year
3 737.006 697.00
3 years
3 191.006 697.00
5 years
2 296.676 697.00
10 years
900.006 697.00
| Managers | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
CEO | Chief Executive Officer | 61 | 87-03-31 |
Junichi Nezu
CTO | Chief Tech/Sci/R&D Officer | - | - |
Hisafumi Okabe
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Masayuki Oku
BRD | Director/Board Member | 79 | 15-02-28 |
Motoo Ueno
BRD | Director/Board Member | 66 | 84-03-31 |
James H. Sabry
BRD | Director/Board Member | 65 | 19-02-28 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 6.57% | 19 M€ | +10.04% | ||
| 1.87% | 57 M€ | +18.84% | ||
| 1.59% | 4 M€ | +19.43% | ||
| 1.53% | 64,792 M€ | +17.08% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-28 | 4,764 | -0.89% | 1 180 500 |
| 24-05-27 | 4,807 | +1.24% | 1,333,100 |
| 24-05-24 | 4,748 | -0.81% | 2,377,800 |
| 24-05-23 | 4,787 | -1.22% | 2,597,800 |
| 24-05-22 | 4,846 | -3.77% | 3,040,300 |
Delayed Quote Japan Exchange, May 28, 2024 at 02:00 am EDT
More quotes
Chugai Pharmaceutical Co. Ltd specializes in the research, development, manufacturing and marketing of drugs especially for cancers (40.8% of net sales), bones and joints diseases treatment (18.4%), and kidney diseases (5.9%).
Net sales are distributed geographically as follows: Japan (74,3%), Switzerland (22,8%) and other (2,9%).
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
4,807
JPY
Average target price
5,975
JPY
Spread / Average Target
+24.30%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -10.82% | 50.44B | |
| +38.51% | 727B | |
| +31.96% | 594B | |
| -6.23% | 354B | |
| +18.78% | 328B | |
| +1.35% | 277B | |
| +15.09% | 243B | |
| +7.97% | 205B | |
| -5.73% | 203B | |
| +6.19% | 164B |
- Stock Market
- Equities
- 4519 Stock
